Fiduciary Alliance’s Bio-Techne TECH Stock Holding History

Fiduciary Alliance’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-252	Closed	-$20.6K	–	861
2023 Q2	$20.6K	Buy	+252	New	+$20.3K	﹤0.01%	445
2023 Q1	–	Sell	-252	Closed	-$20.9K	–	790
2022 Q4	$20.9K	Buy	+252	New	+$20K	0.01%	308

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fiduciary Alliance's TECH Position: Q3 2023 in Review

Fiduciary Alliance sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 252 shares — an estimated $20.6K sold.

Fiduciary Alliance first reported a position in TECH in Q4 2022 and held it in 2 quarters. The position peaked at $20.9K in Q4 2022. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Fiduciary Alliance reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
Fiduciary Alliance sold 252 Bio-Techne shares in Q3 2023, an estimated $20.6K.
Fiduciary Alliance first reported a position in Bio-Techne in Q4 2022 and held it in 2 quarters.
Fiduciary Alliance's Bio-Techne position peaked at $20.9K in Q4 2022.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.